EcoDrugPlus

Glutamate Receptor 4-Like

Ensembl ID : ENSSTUG00000043268
Gene Symbol: LOC115154110
3 Cross references
243 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSSTUG00000022505
Gene Symbol: LOC115204130
3 Cross references
200 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSSTUG00000037756
Gene Symbol: LOC115167675
3 Cross references
151 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSSTUG00000025010
Gene Symbol: LOC115159511
3 Cross references
198 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2b-Like

Ensembl ID : ENSSTUG00000047577
Gene Symbol: LOC115147307
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2b-Like

Ensembl ID : ENSSTUG00000040158
Gene Symbol: LOC115178076
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSSTUG00000029221
Gene Symbol: LOC115176163
2 Cross references
207 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSSTUG00000050736
Gene Symbol: LOC115173146
2 Cross references
206 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2

Ensembl ID : ENSSTUG00000043383
Gene Symbol: LOC115190169
2 Cross references
197 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 2-Like

Ensembl ID : ENSSTUG00000046095
Gene Symbol: LOC115195609
2 Cross references
247 Possible Orthologues:

Glutaminase

Ensembl ID : ENSSTUG00000033711
Gene Symbol: GLS
2 Cross references
223 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSSTUG00000050506
Gene Symbol: LOC115195983
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).